Avanos Medical Inc.

NYSE: AVNS · Real-Time Price · USD
11.20
0.24 (2.19%)
At close: Aug 15, 2025, 3:59 PM
11.22
0.22%
After-hours: Aug 15, 2025, 06:00 PM EDT

Avanos Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
175M 167.5M 179.6M 170.4M 171.7M 166.1M 173.3M 171.3M 169.4M 191.7M 217.5M 202.1M 203M 197.4M 193.4M 184.1M 186.4M 180.7M
Cost of Revenue
82.9M 77.7M 81.6M 77.5M 76.1M 71.3M 75.9M 75.8M 71.6M 87.2M 100.6M 92M 88.1M 90.2M 96.5M 93.7M 100.7M 89.4M
Gross Profit
92.1M 89.8M 98M 92.9M 95.6M 94.8M 97.4M 95.5M 97.8M 104.5M 116.9M 110.1M 114.9M 107.2M 96.9M 90.4M 85.7M 91.3M
Operating Income
-74.5M 10.3M -418.5M 12M 16.1M 7.4M 22.2M 1.2M -2.1M 2.6M 26.2M 18.7M 19M 9.2M 25M 3.6M -7.3M -12.4M
Interest Income
600K 1.5M 800K 700K 3M 600K 1M 900K 500K 500K 700K 300K 200K n/a n/a 200K n/a n/a
Pretax Income
-75.9M 9.7M -420.5M 9.5M 6.2M 1.5M 8.9M -2.6M -5.1M -400K 23.9M 16M 16.5M 7.9M 24.3M 2.9M -8.2M -13.2M
Net Income
-76.8M 6.6M -397.3M 4.3M 1.8M -900K 10.5M -3.7M -68.1M -500K 16.9M 15.7M 11.4M 5.8M 10M -35.1M 37.9M -7.6M
Selling & General & Admin
75.7M 75.7M 79.7M 74.3M 73.2M 80.4M 68.4M 78.7M 93M 92.7M 82.6M 82.1M 87.1M 90.1M 75.2M 75M 76.7M 73.4M
Research & Development
5.8M 5.4M 5.7M 7.2M 6.3M 7M 6.8M 6.1M 6.8M 7.9M 7.5M 7.3M 8M 7.8M 7.6M 8.4M 8M 8.3M
Other Expenses
n/a n/a 431.1M n/a n/a n/a n/a n/a n/a 1.3M 600K 2M 800K 100K -10.9M 3.4M 8.3M 22M
Operating Expenses
81.5M 79.5M 516.5M 80.9M 79.5M 87.4M 75.2M 94.3M 99.9M 101.9M 90.7M 91.4M 95.9M 98M 71.9M 86.8M 93M 103.7M
Interest Expense
-6.2M 2.1M 2.8M 3.2M 3.1M 3.1M 3.3M 4.7M 3.5M 3.5M 3M 3M 2.7M 1.3M 700K 900K 900K 800K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
164.4M 157.2M 598.1M 153.7M 155.6M 158.7M 151.1M 170.1M 171.5M 189.1M 191.3M 183.4M 184M 188.2M 168.4M 180.5M 193.7M 193.1M
Income Tax Expense
-7.1M 3.1M -23.5M 3.6M 1.9M 1M -2.1M 6.2M -800K 100K 7M 300K 5.1M 2.1M 14.3M 38M -46.1M -5.6M
Shares Outstanding (Basic)
46.1M 46.1M 46M 46M 45.9M 46.2M 46.2M 46.8M 46.8M 46.6M 46.5M 46.6M 47.2M 47.4M 48.2M 48.1M 48.1M 47.5M
Shares Outstanding (Diluted)
46.8M 46.8M 46M 46.6M 46.3M 46.2M 46.6M 46.8M 46.8M 46.6M 47M 47M 47.6M 47.8M 48.6M 48.1M 48.6M 48M
EPS (Basic)
-0.14 0.14 -8.64 0.09 0.04 -0.02 0.23 -0.08 -1.46 -0.01 0.36 0.34 0.24 0.12 0.21 -0.73 0.79 -0.16
EPS (Diluted)
-0.14 0.14 -8.64 0.09 0.04 -0.02 0.23 -0.08 -1.46 -0.01 0.36 0.33 0.24 0.12 0.21 -0.73 0.78 -0.16
EBITDA
-80.1M 21.4M -406.6M 24.4M 23M 18.9M 30.3M 13.1M 9.4M 6M 40.3M 24.6M 22.7M 20.3M 34.5M 16.3M 2.2M -2.7M
EBIT
n/a 11.8M -417.7M 12.7M 11.7M 7.5M 18.8M 2.1M -1.6M -6.1M 26.9M 13.1M 10.3M 8.6M 25M 3.6M -7.3M -12.4M
Depreciation & Amortization
10M 9.6M 11.1M 11.7M 11.3M 11.4M 11.5M 11M 10.3M 12.1M 13.4M 11.6M 11.6M 11.1M 9.5M 9.6M 9.5M 9.7M